Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Flint
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Flint, MI

Studies commonly pay $75 to $4,500 per completed study

181 clinical trials are currently recruiting participants within 30 miles of Flint. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

181studies recruiting
5+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Flint right now

Top 25 of 181 recruiting studies, sorted by proximity — each links to its official registry page

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Systemic Lupus Erythematosus Phase 3 Interventional 550 participants sought
Ahmed Arif Medical Research Center — Grand Blanc, Michigan (7.3 mi) · Sponsor: Novartis Pharmaceuticals

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Retina Associates of Michigan — Grand Blanc, Michigan (7.3 mi) · Sponsor: Astellas Pharma Global Development, Inc.

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 340 participants sought
Aa Mrc Llc — Flint, Michigan (0.8 mi) · Sponsor: Novartis Pharmaceuticals

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
Dermatology and Cosmetic Center — Flint, Michigan (0.8 mi) · Sponsor: Incyte Corporation

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia Phase 2 Interventional 186 participants sought
Elite Research Center — Flint, Michigan (0.8 mi) · Sponsor: Zucara Therapeutics Inc.

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 2 Interventional 405 participants sought
AA MRC LLC - Grand Blanc — Grand Blanc, Michigan (7.3 mi) · Sponsor: Boehringer Ingelheim

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: Wake Forest University Health Sciences

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Pancreatic Cancer Phase 2 Interventional 60 participants sought
McLaren Proton Therapy Center — Flint, Michigan (0.8 mi) · Sponsor: Proton Collaborative Group

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi) · Sponsor: Canadian Cancer Trials Group

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought
Genesys Hurley Cancer Institute — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Epiretinal Membrane N/A Interventional 400 participants sought
Retina Associates of Michigan — Grand Blanc, Michigan (7.3 mi) · Sponsor: Jaeb Center for Health Research

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain Phase 3 Interventional 200 participants sought
McLaren Cancer Institute-Flint — Flint, Michigan (0.8 mi) · Sponsor: NRG Oncology

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Atopic Dermatitis Phase 3 Interventional 195 participants sought
Leo Pharma Investigational site — Waterford, Michigan (26.9 mi) · Sponsor: LEO Pharma

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Cancer Hematology Centers - Flint — Flint, Michigan (0.8 mi) · Sponsor: National Cancer Institute (NCI)
Google-rated

Top-rated research centers in Flint

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Elite Clinical Research

★ 5.0
1397 S Linden Rd, Flint, MI 48532
(810) 820-9853

Michigan Cancer Research Consortium

302 Kensington Ave, Flint, MI 48503
(810) 762-8057

Genesys Hurley Cancer Institute

★ 3.7 (41 reviews)
302 Kensington Ave, Flint, MI 48503
(810) 762-8226
"Radiation is wonderful couldn't ask for anything better everyone is so kind and very organized,but as for his chemo doctor she is horrible don't call…"
— Diana Collins, 1★

McLaren Bariatric and Metabolic Institute

★ 3.3
3200 Beecher Rd Ste MBI, Flint, MI 48532
(810) 342-5470

Detroit Clinical Research Center

★ 5.0
30160 Orchard Lake Rd #110, Farmington Hills, MI 48334
(248) 737-5939

Clinical trials in Flint: what's recruiting

The Flint area currently has 181 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Flint, the most active research areas are:

  • Cancer & Oncology16 studies
  • Immune & Skin3 studies
  • Heart & Vascular1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Flint, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Flint

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Flint participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Flint pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Flint?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Flint safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Flint?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Flint

Other metros within reach

More of MI

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts